How much of precision interventional psychiatry can actually happen remotely, and where does the model hit a wall? The answer is potentially more nuanced than the conventional framing suggests. The post Can Precision Psychiatry Be Delivered Remotely? The Limits and Opportunities of Telehealth in Interventional Care appeared first on MedCity News.
Healthcare inefficiency is rarely about a single task. It is typically about disjointed systems, misaligned incentives, and fragmented accountability. When we automate broken processes like these, we simply fail faster and at scale. The post Digitized Dysfunction: Why Healthcare Must Eliminate Work — Not Just Automate It appeared first on MedCity News.
Isomorphic Labs’ Series B financing is the second largest ever raised by a biotech startup. Like the largest one, Isomorphic is also opaque about its drug programs. The post This TechBio Startup Just Raised $2B Without Disclosing a Single Detail About Its Drugs appeared first on MedCity News.
A new American Medical Association survey found that most physicians remain skeptical that insurers’ recent prior authorization reform commitments will meaningfully reduce delays, administrative burdens or patient harm. The post Only 33% of Physicians Believe Health Plans’ Prior Auth Commitments Will Make a Difference appeared first on MedCity News.
CMS imposed a six-month nationwide freeze on new Medicare enrollments for hospices and home health agencies as part of a broader crackdown on fraud in the sectors. The post CMS Halts New Medicare Enrollment for Hospice, Home Care Amid Fraud Crackdown appeared first on MedCity News.
The clinicians working in this system are often deeply committed to their patients. The problem is the system itself which rewards the quantity of time and largely ignores the quality of the treatment’s impact. The post How Value-Based Care Could Finally Fix What’s Broken in Autism Treatment appeared first on MedCity News.
The longer someone waits to seek help, the more their condition progresses, the harder it becomes to intervene, and the easier it becomes to keep waiting. Delay compounds. That’s what makes it so dangerous, and so worth targeting directly. The post Stigma Is The Real Delay In Healthcare appeared first on MedCity News.
Now more than ever, NAMs need to be considered a core aspect of modern drug development – and scientists, decision-makers, regulators and governments must keep pace with this evolving landscape to ensure they are equipped to deliver the next-generation of therapies. The post The Changing Landscape of New Approach Methodologies appeared first on MedCity News.
Healthcare leaders are divided over the Trump administration’s proposed rule to expand employer-sponsored fertility benefits, with some praising broader access and others saying it falls short of guaranteeing comprehensive coverage. The post How Healthcare Leaders are Reacting to the White House’s Proposed Fertility Benefit Rule appeared first on MedCity News.
This year, we are hosting a new event called Bullseye: Targeting Healthier Outcomes & Returns on July 23 in Chicago. It’s invitation-only and exclusively for healthcare investors and corporate business development leads. Join the waitlist for a chance to be in the room with your peers. The post Inviting Investors and Corporate Business Development Leaders…